TSLP rs4795400: Understanding Your Genetic Variant
The rs4795400 variant is a single-nucleotide polymorphism located in the region of the TSLP gene, which plays a critical role in immune system regulation. Research has investigated its association with susceptibility to allergic diseases, including asthma, particularly in the context of environmental exposures.
What each genotype means
Typical TSLP expression
You carry two copies of the common C allele in the TSLP promoter region. In functional and association studies, this genotype is typically associated with standard baseline levels of thymic stromal lymphopoietin expression upon epithelial stimulation. Compared to carriers of the minor T allele, this genotype reflects a standard baseline statistical likelihood for allergic sensitization and childhood-onset asthma, though overall risk is influenced by complex environmental and multi-gene factors.
Carried by approximately 50% to 55% of individuals of European ancestry and is the predominant genotype across most global populations.
Slightly reduced asthma susceptibility
You carry one copy of the protective T allele and one copy of the C allele in the TSLP promoter region. Some association studies suggest that the T allele correlates with slightly altered or attenuated epithelial TSLP induction in response to triggers, conferring a modest protective trend against allergic asthma and eosinophilic airway hyperresponsiveness. Because evidence across diverse populations remains limited and complex, this variant alone does not prevent atopic conditions.
Carried by roughly 35% to 42% of people of European ancestry and is observed at lower frequencies in East Asian populations.
Moderately reduced asthma susceptibility
You carry two copies of the minor T allele in the TSLP promoter region. Published research has linked this homozygous genotype with reduced promoter activity and lower mucosal induction of thymic stromal lymphopoietin, which is associated with a modestly lower statistical risk for asthma and related allergic airway responses. However, evidence remains limited and allergic conditions are multifactorial, meaning lifestyle, environment, and other genetic loci remain critical contributors.
Carried by approximately 7% to 9% of individuals of European ancestry and is relatively uncommon in East Asian and African ancestries.
What is rs4795400?
The rs4795400 variant is a specific change in the DNA sequence, known as a single-nucleotide polymorphism (SNP), located on chromosome 17. While often discussed in the context of the TSLP gene, it is situated in a complex genomic region that includes the GSDMB gene. SNPs are the most common type of genetic variation among people, representing a difference in a single building block of DNA. In the case of rs4795400, individuals may carry different versions of this DNA site, which can influence how genes in the surrounding area are regulated or expressed. Because this region is involved in immune signaling, researchers have focused on whether these variations contribute to differences in how individuals respond to allergens or develop inflammatory conditions.
The Role of TSLP in Immunity
The TSLP gene encodes a protein called thymic stromal lymphopoietin. This protein acts as a key cytokine, a type of signaling molecule that helps coordinate the immune system's response to threats. TSLP is primarily produced by epithelial cells, which line the surfaces of the body, such as the skin and the airways. When these cells encounter allergens or irritants, they release TSLP to activate dendritic cells, which then trigger a T helper type 2 (TH2) immune response. While this process is essential for defending the body against certain pathogens, an overactive TSLP response is linked to chronic inflammation. This pathway is a major focus in medical research, as it is implicated in the development of conditions like atopic dermatitis, allergic rhinitis, and asthma.
Research and Evidence Strength
Scientific studies have explored the link between rs4795400 and allergic phenotypes, with some evidence suggesting an association with asthma risk. However, the strength of this evidence is considered limited and often context-dependent. For example, some research has indicated that the association between this variant and asthma may be more pronounced in children who have been exposed to environmental triggers, such as tobacco smoke. Other studies have highlighted that genetic associations in this region can vary significantly based on ancestry and gender. Because allergic diseases are complex and influenced by a combination of many genes and environmental factors, it is difficult to attribute a specific health outcome solely to this single variant. Current findings should be viewed as statistical associations observed in specific study populations rather than definitive predictors of individual health.
Population Frequency
The frequency of the rs4795400 variant varies across different global populations. In European populations, the minor allele frequency is approximately 0.28. This means that a significant portion of the population carries at least one copy of the less common allele. Because allele frequencies differ by ancestry, the prevalence of specific genotypes will also vary between groups. Understanding these frequencies is important for researchers when designing studies to ensure that findings are representative of diverse populations. It is important to note that having a more common or less common genotype does not inherently imply a health risk, as the clinical significance of this variant remains a subject of ongoing scientific investigation.
Interpreting Your Genetic Information
Genetic information regarding variants like rs4795400 is intended for educational purposes and should not be used to diagnose or treat any medical condition. If you are concerned about asthma, allergies, or other inflammatory symptoms, it is essential to consult with a qualified healthcare professional. They can provide a comprehensive evaluation based on your personal health history, physical examinations, and clinical testing. If you are currently taking medications for allergic conditions, do not make any changes to your treatment plan based on genetic data without first discussing it with your clinician or pharmacist. Genetic variants are only one piece of a much larger puzzle that includes your environment, lifestyle, and overall health, and they should never be used in isolation to make medical decisions.
How common is this variant?
The minor allele frequency for rs4795400 is approximately 0.28 in European populations, though this frequency varies across different ancestral groups.
Frequently asked questions
Is rs4795400 a direct cause of asthma?
No, rs4795400 is not a direct cause of asthma. It is a genetic variant that has been statistically associated with asthma risk in some studies, but asthma is a complex condition influenced by many genes and environmental factors.
Should I be worried if I have the T/T genotype?
Having a specific genotype does not mean you will develop a disease. Genetic associations are statistical trends observed in large groups, and they do not predict individual health outcomes.
Can I use this information to change my allergy medication?
No. You should never change your medication or treatment plan based on genetic information. Always discuss your medications and any health concerns with your doctor or pharmacist.
Where can I find more information about TSLP?
You can find reliable information about the TSLP gene and its role in the immune system through resources like MedlinePlus Genetics or the NCBI Gene database.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4795400?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TSLP
Upstream variant of thymic stromal lymphopoietin linked to elevated eosinophil activation and susceptibility to allergic disease.
An upstream promoter variant that alters thymic stromal lymphopoietin expression, mediating susceptibility to allergic rhinitis and childhood asthma.
A well-characterized intergenic polymorphism upstream of TSLP conferring increased risk of eczema-associated food allergy and allergic eosinophilic airway disease.
Functional TSLP locus variant associated with circulating TSLP levels and predisposition to eosinophilic inflammation and asthma.
Upstream variant that alters thymic stromal lymphopoietin expression, increasing susceptibility to eosinophilic inflammation and food allergy.
Intergenic/promoter region SNP upstream of TSLP that strongly associates with eosinophilic esophagitis, asthma, atopic dermatitis, and allergic sensitization phenotypes.